Commercial Bank Investment and Financial Health Review slide image

Commercial Bank Investment and Financial Health Review

Group Financial Performance - Half Year Ended 30 June 2020 Group Profitability QAR million Consolidated Balance Sheet H1 2020 H1 2019 % QAR million H1 2020 H1 2019 % Net interest income 1571 1218 29.0% Total assets 143,675 141,180 1.8% Non-interest income 426 629 -32.2% Loans & advances 87,000 85,745 1.5% Total costs (470) (552) -14.9% Investment Securities 26,770 23,463 14.1% Net provisions (296) (428) -30.8% Customer Deposits 77,709 77,364 0.4% Associates income (321) 99 -424.2% Net profit after tax 901 948 -5.0% Total equity 21,684 20,477 5.9% Performance Ratios Capital H1 2020 H1 2019 H1 2020 H1 2019 ROAE ROAA NIM 8.2% 9.4% RWA (QAR million) 113,106 112,173 1.2% 1.4% CET 1 ratio (Basel III) 11.5% 11.0% 2.4% 2.0% Total Capital ratio (Basel III) 17.3% 16.3% 21 65 3
View entire presentation